Proposing synchronous oligometastatic non–small‐cell lung cancer based on progression after first‐line systemic therapy

Despite the importance of accurate disease definitions for effective management and treatment decisions, there is currently no consensus on what constitutes oligometastatic non–small‐cell lung cancer (NSCLC). Predominant patterns of initial progressive disease (PD) after first‐line systemic therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyawaki, Taichi, Wakuda, Kazushige, Kenmotsu, Hirotsugu, Miyawaki, Eriko, Mamesaya, Nobuaki, Kobayashi, Haruki, Omori, Shota, Ono, Akira, Naito, Tateaki, Murakami, Haruyasu, Notsu, Akifumi, Mori, Keita, Harada, Hideyuki, Endo, Masahiro, Ohde, Yasuhisa, Takahashi, Kazuhisa, Takahashi, Toshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780027/
https://www.ncbi.nlm.nih.gov/pubmed/33098119
http://dx.doi.org/10.1111/cas.14707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780027/
https://www.ncbi.nlm.nih.gov/pubmed/33098119
http://dx.doi.org/10.1111/cas.14707

Ejemplares similares